You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Here are three things investors need to know post-earnings.
Mr. Market's non-response notwithstanding, Johnson & Johnson (JNJ -0.46%) turned in a great second quarter. But with any company as big as J&J, not every investor question can be answered, and sometimes the leftover question marks are pretty big.
Below are three crucial questions Motley Fool health care analysts Michael Douglass and David Williamson think J&J still needs to answer.
David Williamson owns shares of Johnson & Johnson. Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
